Aquarius AI Inc (AQUA) 銘柄情報

Why so mean? Not a good thing to have in your brain. You should keep a leash on that Ego monster you got there. Only thing that can do that is the Holy Spirit inside you.........

Z

Many will be left with mere scraps as far as share count goes, while some will be slowly selling off their 18+ million shares riding off into the sunset.  And there will also be others who will still be gleefully talking about their beer money they made.....

So among the literate, "No Response" is itself actual data. Failing to report the category is "Data-free."

Oh well, not this week either....

Top 15 at 8:00
Slow very slow

https://ih.advfn.com/markets/nasdaq/premarket

Supervisor from TD Brokerage reached out to the trading desk and the person confirmed it is not halted, I'm so confused getting mixed signals, we'll have to wait until the market opens to see what happens to know for sure.

A governing board of experts is the last thing anyone needs. Unless they’re all saints.

Slaps of millions upon millions in share volumes will occur driving the PPS higher $.05 at a time......

$COEP News January 07, 2025

Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform
https://finance.yahoo.com/news/coeptis-therapeutics-announces-first-customer-130000003.html

BEST SELLERS RANK (BSR) IS 374 17 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec

MDAI......MBOT........VERU.........BNZI.........MULN.................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134

GNPX...76...Added on News...🥳...https://www.prnewswire.com/news-releases/genprex-announces-first-patient-dosed-in-phase-2-expansion-portion-of-acclaim-3-clinical-study-of-reqorsa-gene-therapy-in-combination-with-tecentriq-to-treat-small-cell-lung-cancer-302358445.html

georgie1

GNPX...76...Added on News...🥳...https://www.prnewswire.com/news-releases/genprex-announces-first-patient-dosed-in-phase-2-expansion-portion-of-acclaim-3-clinical-study-of-reqorsa-gene-therapy-in-combination-with-tecentriq-to-treat-small-cell-lung-cancer-302358445.html

georgie1

Looking at the Put Call Ratio, I see that the smart money is looking for a pull back as they were buying Puts a little below the recent highs in the technology sector and the large caps that ran up the most.
I will taper my planned purchases by 1/3.
The 10YT yield is heading up slowly

https://investorshub.advfn.com/uimage/uploads/2025/1/22/gxmfybtc_!_22_capt_8pm_WT_MAGIC.jpg

https://investorshub.advfn.com/uimage/uploads/2025/1/22/jdzuyBTC_!_22_1M_6pm_100k_ON_DIAG.jpg


https://investorshub.advfn.com/uimage/uploads/2025/1/22/ulhfvBTC_!_22_1M_612

GNPX...76...Added on News...🥳...https://www.prnewswire.com/news-releases/genprex-announces-first-patient-dosed-in-phase-2-expansion-portion-of-acclaim-3-clinical-study-of-reqorsa-gene-therapy-in-combination-with-tecentriq-to-treat-small-cell-lung-cancer-302358445.html

georgie1

News next week regarding a new potentially pivotal trial for treatment of Parkinson’s disease with Anavex’s blarcamesine.

Good luck and GOD bless,

updated

GERN 70000 shares

Cash $35764

The television advertising will showcase SGTM's brand on major networks such as ESPN2, THE DISCOVERY CHANNEL, PURSUIT NETWORK, WFN, ATT SPORTS SW, and other networks as they become available.

With No substance, no communication, and no game plan, I highly doubt these slant-eyed scamming communist chinamen can pull off another pump and dump. Even the real pumpers are MIA. There are zero reasons to buy this garbage, which is obvious. FFS😆

This is dead, right? Liquidation 6 years ago?

“For so long, people were like, ‘You can't do work in pain, because everything fails,’” CBO James Hackworth, told Fierce. “Now, after decades of nothing new, it looks like we're on the cusp of two things that are very new that will succeed.”

Tris Pharma's alternative to opioids reduce

It is halted
https://www.otcmarkets.com/stock/TWOH/security

A key product in SGTM's portfolio, HumiSoil is a patented formula invented by VRM Biologik designed to replenish organic nutrients and water solubility in depleted soils. In today's agricultural practices, soil often loses vital nutrients, leading to reduced crop yields and hampering carbon dioxide

You were the one pumping "contracts".  Than you went silent about it.

Funny how that works.